Tamar Thompson serves as Executive at CATALYST PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Tamar Thompson has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 8, 2025 involved exercising options for 1,413 shares valued at $0.
Tamar Thompson currently holds 3,773 shares of CATALYST PHARMACEUTICALS, INC. (CPRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tamar Thompson has been a net neutral trader of CPRX stock. They have purchased $0 and sold $0 worth of shares.
Tamar Thompson's most recent insider trade was on Dec 8, 2025, when they sold 1,413 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |